Abiopharma

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Vicarious Surgical Inc. - Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Schrödinger, Inc. - Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Allurion - Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results

Mirum Pharma - Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum

Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting